Aptus Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$977K	Sell	1,264 -399	-24%	-$305K	0.01%	590
2025 Q4	$1.28M	Buy	1,663 +161	+11%	+$109K	0.01%	529
2025 Q3	$845K	Sell	1,502 -11	-0.7%	-$6.22K	0.01%	581
2025 Q2	$794K	Sell	1,513 -73	-5%	-$40.7K	0.01%	573
2025 Q1	$1.01M	Sell	1,586 -13	-0.8%	-$8.94K	0.01%	509
2024 Q4	$1.14M	Buy	1,599 +625	+64%	+$525K	0.01%	478
2024 Q3	$1.02M	Buy	974 +32	+3%	+$35.6K	0.02%	405
2024 Q2	$990K	Buy	942 +39	+4%	+$37.8K	0.02%	394
2024 Q1	$869K	Buy	903 +124	+16%	+$118K	0.02%	415
2023 Q4	$684K	Sell	779 -25	-3%	-$20.6K	0.02%	332
2023 Q3	$662K	Buy	804 +310	+63%	+$244K	0.02%	339
2023 Q2	$355K	Buy	494 +40	+9%	+$30.8K	0.01%	371
2023 Q1	$373K	Buy	454 +91	+25%	+$68.6K	0.01%	353
2022 Q4	$262K	Sell	363 -140	-28%	-$103K	0.01%	427
2022 Q3	$347K	Sell	503 -4	-0.8%	-$2.52K	0.01%	369
2022 Q2	$300K	Sell	507 -72	-12%	-$46.8K	0.01%	326
2022 Q1	$404K	Buy	+579	New	+$366K	0.01%	323